Filter
70
Filtered Results: 70
Text search:
neurocysticercosis
Featured
Recommendations
9
New Publications
12
Language
Document type
No document type
43
Studies & Reports
12
Guidelines
8
Strategic & Response Plan
4
Manuals
3
Countries / Regions
Global
5
Latin America and the Carribbean
4
India
4
Uganda
3
Africa
2
Ukraine
1
Chile
1
Philippines
1
South–East Asia Region
1
Western and Central Europe
1
North America
1
Sudan
1
South Sudan
1
Liberia
1
Authors & Publishers
Publication Years
Category
NTDs & Others
5
Taeniasis/ Cysticercosis
3
Guidelines
3
Disease Prevention & Control
2
Communicable Diseases
1
Paediatrics
1
Helminthiasis
1
Pharmacy & Technology
1
Trachoma
1
Onchocerciasis
1
Schistosomiasis
1
Lymphaticfilariasis
1
Pediatrics
1
Policies & Guidelines HIV & TB
1
Drugs & Medical Equipment
1
Women & Child Health
1
Disabilities
1
Studies & Reports
1
Statistics
1
General Guidelines
1
Communicable Diseases
1
Gynaecology & Obstetrics
1
Leprosy
1
Maternal Health
1
Toolboxes
Epilepsy
24
Neurological Disorders
17
Epilepsy
14
Neurological disorders, Others
5
Taeniasis/Cysticercosis
4
Children/Adolescents Mental Disorders
3
Rational use of Medicine
3
Strategies & Roadmaps
3
Overview, Studies & Reports
3
Latin America
2
Africa
2
IACAPAP International Association for Child and Adolescent Psychiatry and Allied Professions
2
Latin America
2
Essential Medicines
2
Essential Medicines & Devices Lists
2
Zoonoses
2
Substance Use Disorders & Addiction
2
Asia
2
Mental Health GAP Action Programme
2
Africa
1
Key Resources
1
Statistics & Data
1
Substance Use Disorders, Others
1
Studies & Reports
1
TB & Other Vulnerable Populations
1
Training Supporting Material mhGAP
1
Mental Disorders
1
Guidelines & Manuals
1
Studies & Reports
1
NTDs General
1
Asia
1
others
1
Modules
1
IEC Materials Children
1
Community-based Mental Health Care
1
IEC Material Neurological Disorders
1
Meningitis & Encephalitis
1
Disease Control Priorities, 3rdEdition: Volume 4.
Mental, neurological, and substance use disorders are common, highly disabling, and associated with significant premature mortality. The impact of these disorders on the social and economic well-beingof individuals, families, and societies is large...
What you can do
Epilepsia, 55(4):475–482, 2014
doi: 10.1111/epi.12550
Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 19, No. 9, September 2013
African Health Sciences 2013; 13(2): 219 - 232 http://dx.doi.org/10.4314/ahs.v13i2.4
WHO Technical Series 971
www.jogh.org • doi: 10.7189/jogh.02.020405 ~ December 2012 • Vol. 2 No. 2 • 020405
Int J Crit Illn Inj Sci. 2012 May-Aug; 2(2): 82–97.
doi: 10.4103/2229-5151.97273
PMCID: PMC3401822
PMID: 22837896
October 2009 | Volume 6 | Issue 10 | e1000162
Neurology Asia 2008; 13 : 41 – 48
Statement
Impact of migration on infectious diseases in Europe | August 2007 | 1-7
Coordinated Use of Anthelminthic Drugs in Control Interventions: a Manual for Health Professionals and Programme Managers
Bridging the Gap
Global Campaign Against Epilepsy
The Global Campaign Against Epilepsy “Out of the Shadows”
L’objectif de cette note conceptuelle et du cadre dont elle donne les grandes lignes est l’élimination d’un groupe de MT et de leurs effets pénalisants sur la santé (maladies énumérées au tableau 1 ci-dessous) qui, pris globalement, génèrent une charge tangible pour les personnes touch...
